Cytek Biosciences Inc expected to post earnings of 2cents a share - Earnings Preview

Cytek Biosciences

08/11/2022 03:04

* Cytek Biosciences Inc  CTKB.OQ   CTKB.O  is expected
to show a
fall in quarterly revenue when it reports  results on November
9. 
    * The Fremont California-based  company is expected to
report  a
32.2% decrease in revenue to $43.288 million from $63.84 million
a year ago, according to the mean estimate from 3 analysts,
based on Refinitiv data. 
    * ​Refinitiv's mean analyst estimate for Cytek Biosciences
Inc is
for earnings of 2 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Cytek
Biosciences
Inc is $16​, above​ its last closing price of $14.70. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Jun. 30 2022  0.03        0.02       0.03      Beat    80
 Mar. 31 2022  -0.01       0.00       0.01      Beat    300
 Dec. 31 2021  0.02        0.03       0.03      Met     20​
 Sep. 30 2021  0.03        0.02       0.02      Met     -14.3
 ​​Jun.        0.02        0.02       0.00      Missed  -100
 30 2021                                                
                                                        ​
 This summary was machine generated November 8 at 03:03 GMT.  All
figures in US dollars  unless otherwise stated